Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

EURECA project: Data mining and knowledge recovery

Ruud Van Stiphout - University of Oxford, Oxford, UK
EURECA project: Data mining and knowledge recovery ( Ruud Van Stiphout - University of Oxford, Oxford, UK )
20 Feb 2014

ecancermedicalscience Editor's Choice: The personalised medicine project

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience Editor's Choice: The personalised medicine project ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
19 Feb 2014

ecancermedicalscience Editor's Choice for January 2014

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience Editor's Choice for January 2014 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
12 Feb 2014

Multiple Myeloma Debate 2014: Recent advances in multiple myeloma

Dr Pieter Sonneveld, Prof Michele Cavo, Dr Jesus San Miguel and Dr Meletios Dimopoulos
Multiple Myeloma Debate 2014: Recent advances in multiple myeloma ( Dr Pieter Sonneveld, Prof Michele Cavo, Dr Jesus San Miguel and Dr Meletios Dimopoulos )
2 Feb 2014

Critical insights on leukaemia and lymphoma from ASH 2013

Prof Robin Foa, Dr Simon Rule, Dr Clemens Wendtner
Critical insights on leukaemia and lymphoma from ASH 2013 ( Prof Robin Foa, Dr Simon Rule, Dr Clemens Wendtner )
2 Feb 2014

Impact of the cost of cancer care on Europe

Prof Richard Sullivan - King's College London, London, UK
Impact of the cost of cancer care on Europe ( Prof Richard Sullivan - King's College London, London, UK )
2 Feb 2014

Predictive power of PSA patterns during off-time treatment periods with intermittent androgen deprivation

Dr Rafael Sanchez-Salas - Institut Mutualiste Montsouris, Paris, France
Predictive power of PSA patterns during off-time treatment periods with intermittent androgen deprivation ( Dr Rafael Sanchez-Salas - Institut Mutualiste Montsouris, Paris, France )
1 Feb 2014

ALSYMPCA trial: Ra-223 effective and well-tolerated for CRPC with symptomatic bone metastases

Dr Sten Nilsson - Karolinska University Hospital, Stockholm, Sweden
ALSYMPCA trial: Ra-223 effective and well-tolerated for CRPC with symptomatic bone metastases ( Dr Sten Nilsson - Karolinska University Hospital, Stockholm, Sweden )
1 Feb 2014

Results of the MARS study in renal cell carcinoma

Dr Vincent Launay-Vacher - Pitie-Salpetriere Hospital, Paris, France
Results of the MARS study in renal cell carcinoma ( Dr Vincent Launay-Vacher - Pitie-Salpetriere Hospital, Paris, France )
31 Jan 2014

Results of orteronel plus prednisone in the TAK-700 trial on mCRPC

Dr Robert Dreicer - Cleveland Clinic, Cleveland, USA
Results of orteronel plus prednisone in the TAK-700 trial on mCRPC ( Dr Robert Dreicer - Cleveland Clinic, Cleveland, USA )
31 Jan 2014

MET variant as a prognostic marker in clear cell renal cell carcinoma

Dr Ari Hakimi - Memorial Sloan-Kettering Cancer Center, New York, USA
MET variant as a prognostic marker in clear cell renal cell carcinoma ( Dr Ari Hakimi - Memorial Sloan-Kettering Cancer Center, New York, USA )
31 Jan 2014

Enzalutamide improves survival in men with metastatic castration-resistant prostate cancer

Dr Tomasz M. Beer - Oregon Health & Science University, Portland, USA
Enzalutamide improves survival in men with metastatic castration-resistant prostate cancer ( Dr Tomasz M. Beer - Oregon Health & Science University, Portland, USA )
31 Jan 2014